151 related articles for article (PubMed ID: 20309654)
1. Two-step solid lipid extrusion as a process to modify dissolution behavior.
Windbergs M; Gueres S; Strachan CJ; Kleinebudde P
AAPS PharmSciTech; 2010 Mar; 11(1):2-8. PubMed ID: 20309654
[TBL] [Abstract][Full Text] [Related]
2. Dissolution from solid lipid extrudates containing release modifiers.
Güres S; Kleinebudde P
Int J Pharm; 2011 Jun; 412(1-2):77-84. PubMed ID: 21515350
[TBL] [Abstract][Full Text] [Related]
3. Tailor-made dissolution profiles by extruded matrices based on lipid polyethylene glycol mixtures.
Windbergs M; Strachan CJ; Kleinebudde P
J Control Release; 2009 Aug; 137(3):211-6. PubMed ID: 19358867
[TBL] [Abstract][Full Text] [Related]
4. Analysis of matrix dosage forms during dissolution testing using raman microscopy.
Haaser M; Windbergs M; McGoverin CM; Kleinebudde P; Rades T; Gordon KC; Strachan CJ
J Pharm Sci; 2011 Oct; 100(10):4452-9. PubMed ID: 21560128
[TBL] [Abstract][Full Text] [Related]
5. Solid lipid extrudates as sustained-release matrices: the effect of surface structure on drug release properties.
Reitz C; Strachan C; Kleinebudde P
Eur J Pharm Sci; 2008 Nov; 35(4):335-43. PubMed ID: 18765281
[TBL] [Abstract][Full Text] [Related]
6. Preparation of extruded carbamazepine and PEG 4000 as a potential rapid release dosage form.
Perissutti B; Newton JM; Podczeck F; Rubessa F
Eur J Pharm Biopharm; 2002 Jan; 53(1):125-32. PubMed ID: 11777760
[TBL] [Abstract][Full Text] [Related]
7. Improvement of dissolution behavior for poorly water-soluble drug by application of cyclodextrin in extrusion process: comparison between melt extrusion and wet extrusion.
Yano H; Kleinebudde P
AAPS PharmSciTech; 2010 Jun; 11(2):885-93. PubMed ID: 20496019
[TBL] [Abstract][Full Text] [Related]
8. Fatty acids for controlled release applications: A comparison between prilling and solid lipid extrusion as manufacturing techniques.
Vervaeck A; Monteyne T; Siepmann F; Boone MN; Van Hoorebeke L; De Beer T; Siepmann J; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):173-84. PubMed ID: 26428938
[TBL] [Abstract][Full Text] [Related]
9. Understanding the solid-state behaviour of triglyceride solid lipid extrudates and its influence on dissolution.
Windbergs M; Strachan CJ; Kleinebudde P
Eur J Pharm Biopharm; 2009 Jan; 71(1):80-7. PubMed ID: 18588976
[TBL] [Abstract][Full Text] [Related]
10. Solid lipid extrusion with small die diameters--electrostatic charging, taste masking and continuous production.
Witzleb R; Kanikanti VR; Hamann HJ; Kleinebudde P
Eur J Pharm Biopharm; 2011 Jan; 77(1):170-7. PubMed ID: 20940049
[TBL] [Abstract][Full Text] [Related]
11. Influence of the composition of glycerides on the solid-state behaviour and the dissolution profiles of solid lipid extrudates.
Windbergs M; Strachan CJ; Kleinebudde P
Int J Pharm; 2009 Nov; 381(2):184-91. PubMed ID: 19782882
[TBL] [Abstract][Full Text] [Related]
12. Investigating the relationship between drug distribution in solid lipid matrices and dissolution behaviour using Raman spectroscopy and mapping.
Windbergs M; Haaser M; McGoverin CM; Gordon KC; Kleinebudde P; Strachan CJ
J Pharm Sci; 2010 Mar; 99(3):1464-75. PubMed ID: 19691104
[TBL] [Abstract][Full Text] [Related]
13. Drug release from extruded solid lipid matrices: theoretical predictions and independent experiments.
Güres S; Siepmann F; Siepmann J; Kleinebudde P
Eur J Pharm Biopharm; 2012 Jan; 80(1):122-9. PubMed ID: 22008146
[TBL] [Abstract][Full Text] [Related]
14. Thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding.
Claeys B; Vervaeck A; Hillewaere XK; Possemiers S; Hansen L; De Beer T; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2015 Feb; 90():44-52. PubMed ID: 25448075
[TBL] [Abstract][Full Text] [Related]
15. Novel Controlled Release Polymer-Lipid Formulations Processed by Hot Melt Extrusion.
Maniruzzaman M; Islam MT; Halsey S; Amin D; Douroumis D
AAPS PharmSciTech; 2016 Feb; 17(1):191-9. PubMed ID: 26689407
[TBL] [Abstract][Full Text] [Related]
16. Solid lipid extrusion of sustained release dosage forms.
Reitz C; Kleinebudde P
Eur J Pharm Biopharm; 2007 Sep; 67(2):440-8. PubMed ID: 17481868
[TBL] [Abstract][Full Text] [Related]
17. Lipid extrudates as novel sustained release systems for pharmaceutical proteins.
Schulze S; Winter G
J Control Release; 2009 Mar; 134(3):177-85. PubMed ID: 19121347
[TBL] [Abstract][Full Text] [Related]
18. Hot-melt extrusion for enhanced delivery of drug particles.
Miller DA; McConville JT; Yang W; Williams RO; McGinity JW
J Pharm Sci; 2007 Feb; 96(2):361-76. PubMed ID: 17075869
[TBL] [Abstract][Full Text] [Related]
19. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
[TBL] [Abstract][Full Text] [Related]
20. Analyzing the impact of different excipients on drug release behavior in hot-melt extrusion formulations using FTIR spectroscopic imaging.
Pudlas M; Kyeremateng SO; Williams LAM; Kimber JA; van Lishaut H; Kazarian SG; Woehrle GH
Eur J Pharm Sci; 2015 Jan; 67():21-31. PubMed ID: 25445833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
